Upgrade to SI Premium - Free Trial

RBC Capital on Boston Scientific (BSX): 'We Are Bullish on the LT Thesis At Current Valuations'

April 2, 2026 8:06 AM
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $115.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments